Skip to main content
Equibles
AHCO logo

AHCO · AdaptHealth Corp.

Track AHCO — free

Use AHCO with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$6.49 +0.07 (+1.09%) At close · Sep 4
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$884.87M
Shares
136.34M

AHCO metrics

80 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$6.49
Market cap
$884.87M

Price action

19 metrics
Price change (1W)
+12.1%
Price change (30D)
+24.3%
Price change (3M)
-34.4%
Price change (6M)
-31.6%
Price change (YTD)
-34.8%
Price change (1Y)
-29.5%
Trailing year
Price change (5Y)
-73.4%
52-week high
$13.38
52-week low
$5.22
Change from 52-week high
-51.5%
Change from 52-week low
+24.3%
Annualized volatility
62.0%
Beta
0.0
RSI (14D)
47.4
Price vs SMA 50
-21.9%
Price vs SMA 200
-35.0%
Avg volume (3M)
2.50M
Relative volume
1.1
Average dollar volume
$18.52M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
136.34M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.3×
reciprocal yield 380.8%
P / book
0.6
reciprocal yield 155.8%
FCF yield
11.0%
TTM · current market cap
Buyback yield
0.0%
P / FCF
9.1
reciprocal yield 11.0%
P / operating cash flow
1.5
reciprocal yield 65.9%
Earnings yield
-25.9%

Historical valuation

8 metrics
P / E historical average (3Y)
22.7×
reciprocal yield 4.4%
P / E historical average (5Y)
26.5×
reciprocal yield 3.8%
EV / revenue historical average (3Y)
1.0×
reciprocal yield 97.2%
EV / revenue historical average (5Y)
1.3×
reciprocal yield 74.4%
EV / EBIT historical average (3Y)
21.8×
reciprocal yield 4.6%
EV / EBIT historical average (5Y)
22.5×
reciprocal yield 4.4%
EV / EBITDA historical average (3Y)
16.0×
reciprocal yield 6.3%
EV / EBITDA historical average (5Y)
13.9×
reciprocal yield 7.2%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
16.9%
Operating margin
-3.9%
Trailing 12 months
Net margin
-6.8%
Gross profit (TTM)
—
Operating profit (TTM)
−$130.30M
Net income (TTM)
−$229.36M
Trailing 12 months
Diluted EPS (TTM)
$-1.68
FCF margin
2.9%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.00

Growth

11 metrics
Revenue growth YoY
+12.7%
Year over year
Net income growth YoY
-1,012.7%
Revenue (TTM)
$3.37B
Trailing 12 months
EPS growth YoY
-1,090.0%
Shares change YoY
-0.7%
Year over year · fewer shares
Revenue CAGR (3Y)
+3.0%
Revenue CAGR (5Y)
+25.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
+7.1%

Quality

14 metrics
Return on equity
-16.6%
Return on assets
-5.3%
Debt / equity
1.4
Current ratio
1.1
EBITDA (TTM)
$291.68M
Free cash flow (TTM)
$97.68M
Quick ratio
1.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$1.78B
Latest balance sheet
Cash & equivalents
$47.96M
Total assets
$4.34B
Total debt
$1.89B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$583.27M
Capital expenditures (TTM)
$485.59M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$22.54M
R&D / revenue
—
Stock compensation / revenue
0.7%

Ownership (13F)

3 metrics
13F filers
240
13F filer change QoQ
-2
Institutional ownership
104.8%

Short interest

3 metrics
Short interest
5.6%
Latest settlement · 1.1 days to cover
Days to cover
1.1d
Short-squeeze score
46 / 100

Insider activity

2 metrics
Net insider buying (90D)
$158,219
Insider-sentiment score
87 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1725255 CUSIP 00653Q102 13F (30d) 162 filings 161 filers Visit website Investor relations